|
SLFN11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.67969971265336E-10 |
| Normal-vs-Stage3 |
4.44089209850063E-16 |
| Normal-vs-Stage4 |
1.64535052249448E-12 |
| Stage1-vs-Stage2 |
9.332000E-01 |
| Stage1-vs-Stage3 |
9.383400E-01 |
| Stage1-vs-Stage4 |
1.267980E-01 |
| Stage2-vs-Stage3 |
8.977800E-01 |
| Stage2-vs-Stage4 |
2.183400E-01 |
| Stage3-vs-Stage4 |
1.686020E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.49169999999577E-05 |
| Normal-vs-Asian |
2.87481149996438E-12 |
| Caucasian-vs-AfricanAmerican |
1.651830E-01 |
| Caucasian-vs-Asian |
6.404200E-01 |
| AfricanAmerican-vs-Asian |
1.865160E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.664600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.4432899320127E-14 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64712687933388E-12 |
| Normal-vs-Age(81-100Yrs) |
1.843900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.992600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.729200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.061600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.818800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.968000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.246200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.217900E-03 |
| Classical-VS-Follicular |
1.344020E-01 |
| Classical-VS-Other |
8.083600E-01 |
| Classical-VS-Normal |
9.84767822842514E-14 |
| Tall-VS-Follicular |
1.377040E-03 |
| Tall-VS-Other |
1.205830E-01 |
| Tall-VS-Normal |
1.6251444634463E-12 |
| Follicular-VS-Other |
7.726600E-01 |
| Follicular-VS-Normal |
1.34190003553414E-09 |
| Other-VS-Normal |
1.263970E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.34781075189494E-13 |
| N0-vs-N1 |
1.300200E-01 |
|
|
